Medication Talk
TRC Healthcare
The official podcast of TRC Healthcare, home of Pharmacist’s Letter, Prescriber Insights, RxAdvanced, and the most trusted clinical resources.
Listen in as we discuss current topics impacting medication therapy and patient care.
TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.
All episodes
Best episodes
Seasons
Top 10 Medication Talk Episodes
Goodpods has curated a list of the 10 best Medication Talk episodes, ranked by the number of listens and likes each episode have garnered from our listeners. If you are listening to Medication Talk for the first time, there's no better place to start than with one of these standout episodes. If you are a fan of the show, vote for your favorite Medication Talk episode by adding your comments to the episode page.
Specialty Meds: Navigating Barriers
Medication Talk
08/01/24 • 39 min
In this episode, listen in as our expert panel discusses the challenges and solutions for ensuring access to specialty medications, including how social determinants of health play a role and strategies to overcome barriers caused by these factors.
Our panel for this conversation includes:
- Laura Sosinski, PharmD, MBA, BCPS; Pharmacy Manager, Walgreens Specialty Pharmacy; PGY1 Community Pharmacy Residency Director
- Patricia Romero, PharmD, CSP; Pharmacist, Walmart Specialty Pharmacy
- Rachel Popp, CPhT; Patient Panelist; Contact Center Specialist, Walmart Specialty Pharmacy
- Jake Galdo, PharmD, MBA, BCPS, BCGP; CEO, Seguridad, Inc; Managing Network Facilitator, CPESN Health Equity
- Meredy Ayers, CPhT-Adv, CHW; Development Specialist, Bremo Pharmacy
None of the speakers have anything to disclose.
TRC Healthcare offers CE credit for this podcast episode. Log in to your Pharmacist’s Letter,Prescriber Insights, or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses.
The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter and Prescriber Insights:
If you’re not yet a Pharmacist’s Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com.
Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.
You can also reach out to provide feedback or make suggestions by emailing us at [email protected].
Managing Chronic Coronary Disease
Medication Talk
11/01/23 • 33 min
Special guest Dave L. Dixon, PharmD, FACC, FAHA, FCCP, FNLA, BCACP, CDCES, CLS, the Nancy L. and Ronald H. McFarlane Professor of Pharmacy and Chair of the Department of Pharmacotherapy & Outcomes Science at the Virginia Commonwealth University School of Pharmacy, joins us to talk about chronic coronary disease.
Listen in as he discusses the management of chronic coronary disease with a focus on the new American College of Cardiology/American Heart Association guidelines.
You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:
- Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Tower Health System Internal Medicine Residency Program and Professor of Medicine at the Drexel University College of Medicine
- Steven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute and the Lewis and Patricia Dickey Chair in Cardiovascular Medicine Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University
- Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor of Pharmacy Practice at the Oregon Health and Science University
For the purposes of disclosure, Dr. Dixon reports a relevant financial relationship [GLP-1 agonists, SGLT2 inhibitors] with Boehringer Ingelheim (grants/research support). Dr. Steven Nissen reports relevant financial relationships [cardiology] with AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Esperion, Medtronic, MyoKardia, New Amsterdam Pharma, Novartis, Pfizer, Silence Therapeutics (grants/research support).
The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.
TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter or Prescriber’s Letter account and look for the title of this podcast in the list of available CE courses.
Claim Credit
The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter and Prescriber’s Letter:
- Toolbox: Optimizing Care of Patients with Coronary Artery Disease
- Chart: Dual Antiplatelet Therapy for Coronary Artery Disease
- Chart: Treatment of Hypertension
If you’re not yet a Pharmacist’s Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com.
Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.
You can also reach out to provide feedback or make suggestions by emailing us at [email protected].
Vaccine FAQs
Medication Talk
12/01/23 • 33 min
Special guest Shana Castillo, PharmD, MBA, RPh, Associate Professor of Pharmacy Practice at Creighton University’s School of Pharmacy and Health Professions joins us to talk about vaccinations.
Listen in as they discuss the latest recommendations for COVID-19 and influenza vaccinations, along with options to prevent respiratory syncytial virus (RSV), and practical approaches for giving multiple vaccines in a single visit.
You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:
- Reid B. Blackwelder, MD, FAAFP, Associate Dean of Graduate and Continuing Medical Education and Professor of Family Medicine at East Tennessee State University
- Stephen Carek, MD, CAQSM, DipABLM, Clinical Assistant Professor of Family Medicine, Prisma Health/USC-SOMG Family Medicine Residency Program at the USC School of Medicine Greenville
- Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor of Pharmacy Practice at the Oregon Health and Science University
None of the speakers have anything to disclose.
TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.
Claim Credit
The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter and Prescriber Insights:
- Chart: COVID-19 Vaccines
- FAQ: Flu Vaccines for 2023-24
- Chart: Preventing RSV
- Algorithm: Addressing Vaccine Myths and Hesitancy
If you’re not yet a Pharmacist’s Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com.
Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.
You can also reach out to provide feedback or make suggestions by emailing us at [email protected].
New Opioid Guidelines
Medication Talk
02/01/23 • 32 min
Special guest Laila Khalid, MD, MPH from the Albert Einstein College of Medicine Montefiore Medical Center joins us to talk about new guidelines to reinforce safe opioid use.
Listen in as they discuss what’s changed with the updated CDC opioid guidelines...and what to expect in your practice.
You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:
- Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
- Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
- Joseph Scherger, MD, MPH, Family Physician, Primary Care 365, Eisenhower Health
None of the speakers have anything to disclose.
Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.
Claim Credit
If you’re not yet a Pharmacist’s Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com.
Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.
You can also reach out to provide feedback or make suggestions by emailing us at [email protected].
New Heart Failure Guidelines
Medication Talk
06/01/22 • 30 min
TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with two distinguished experts about new heart failure guidelines.
- Carolyn Lam, MBBS, PhD, FRCP, Professor at Duke-NUS Medical School and a Senior Consultant at the National Heart Centre Singapore
- Steven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute and the Lewis and Patricia Dickey Chair in Cardiovascular Medicine Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University
Listen in as they discuss new guidelines for managing heart failure with reduced ejection fraction (HFrEF)...and put this new guidance in perspective.
You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:
- Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor Health
- Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
- Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science University
For the purposes of disclosure, Dr. Carolyn Lam reports relevant financial relationships with Bayer, Roche Diagnostics (grants/research support); Abbott, Actelion, Alleviant Medical, Allysta Pharmaceuticals, Amgen, AnaCardio AB, Applied Therapeutics, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Cytokinetics, Darma Inc., EchoNous Inc, Impulse Dynamics, Ionis Pharmaceuticals, Janssen, Merck, Novartis, Novo Nordisk, Roche Diagnostics, Sanofi, Siemens Healthcare Diagnostics, Us2.ai (advisory board/steering committee/executive committee); Us2.ai (stock shareholder); Us2.ai (non-executive director).
Dr. Steven Nissen reports a relevant financial relationship with AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Esperion, Medtronic, Novartis, Pfizer, Silence Therapeutics (grants/research support).
The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.
Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.
If you’re not yet a Pharmacist’s Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com.
Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.
You can also reach out to provide feedback or make suggestions by emailing us at [email protected].
RSV Vaccines in Older Adults
Medication Talk
09/11/23 • 30 min
Special guests Lauren B. Angelo, PharmD, MBA from the Rosalind Franklin University of Medicine and Science and Jean-Venable “Kelly” R. Goode, PharmD, BCPS, FAPhA, FCCP from the Virginia Commonwealth University School of Pharmacy join us to talk about respiratory syncytial virus (RSV) vaccines.
Listen in as they review new RSV vaccine recommendations in adults age 60 years and older.
You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:
- Reid B. Blackwelder, MD, FAAFP, Associate Dean of Graduate and Continuing Medical Education and Professor of Family Medicine at East Tennessee State University
- Stephen Carek, MD, CAQSM, DipABLM, Clinical Assistant Professor of Family Medicine, Prisma Health/USC-SOMG Family Medicine Residency Program at the USC School of Medicine Greenville
- Andrea Darby Stewart, MD, Associate Director, Honor Health Family Medicine Residency Program and Clinical Professor of Family, Community & Occupational Medicine at the University of Arizona College of Medicine - Phoenix
- Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Tower Health System Internal Medicine Residency Program and Professor of Medicine at the Drexel University College of Medicine
For the purposes of disclosure, Dr. Angelo reports relevant financial relationships [vaccines] with Moderna (honorarium); Pfizer (speakers bureau). Dr. Goode reports relevant financial relationships [vaccines] with Merck, Pfizer, Sanofi, Valneva (honorarium).
The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.
TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter or Prescriber’s Letter account and look for the title of this podcast in the list of available CE courses.
Claim Credit
If you’re not yet a Pharmacist’s Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com.
Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.
You can also reach out to provide feedback or make suggestions by emailing us at [email protected].
Debate About LDL Targets
Medication Talk
07/01/23 • 31 min
Special guest Steven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute, Lewis and Patricia Dickey Chair in Cardiovascular Medicine, and Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University joins us to talkabout LDL targets.
Listen in as they debate whether to aim for a specific goal for LDL cholesterol.
You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:
- Stephen Carek, MD, CAQSM, DipABLM, Clinical Assistant Professor of Family Medicine, Prisma Health/USC-SOMG Family Medicine Residency Program at the USC School of Medicine Greenville
- Andrea Darby Stewart, MD, Associate Director, Honor Health Family Medicine Residency Program and Clinical Professor of Family, Community & Occupational Medicine at the University of Arizona College of Medicine - Phoenix
- Anthony A. Donato, Jr., MD, MHPE, Associate Director, Reading Health System Internal Medicine Residency Program and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University
- Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor of Pharmacy Practice at the Oregon Health and Science University
For the purposes of disclosure, Dr. Steven Nissen reports relevant financial relationships [cardiology] with AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Esperion, Medtronic, MyoKardia, New Amsterdam Pharma, Novartis, Pfizer, Silence Therapeutics (grants/research support).
The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.
Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.
Claim Credit
The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter:
If you’re not yet a Pharmacist’s Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com.
Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.
You can also reach out to provide feedback or make suggestions by emailing us at [email protected].
Flu Vaccine Updates
Medication Talk
10/02/23 • 25 min
Special guests Lauren B. Angelo, PharmD, MBA from the Rosalind Franklin University of Medicine and Science and Jean-Venable “Kelly” R. Goode, PharmD, BCPS, FAPhA, FCCP from the Virginia Commonwealth University School of Pharmacy join us to talkabout influenza vaccines.
Listen in as they review flu vaccine recommendations for the 2023-2024 influenza season.
You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:
- Reid B. Blackwelder, MD, FAAFP, Associate Dean of Graduate and Continuing Medical Education and Professor of Family Medicine at East Tennessee State University
- Stephen Carek, MD, CAQSM, DipABLM, Clinical Assistant Professor of Family Medicine, Prisma Health/USC-SOMG Family Medicine Residency Program at the USC School of Medicine Greenville
- Andrea Darby Stewart, MD, Associate Director, Honor Health Family Medicine Residency Program and Clinical Professor of Family, Community & Occupational Medicine at the University of Arizona College of Medicine - Phoenix
- Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Tower Health System Internal Medicine Residency Program and Professor of Medicine at the Drexel University College of Medicine
- Douglas S. Paauw, MD, MACP, Professor of Medicine at the University of Washington School of Medicine
For the purposes of disclosure, Dr. Angelo reports relevant financial relationships [vaccines] with Moderna (honorarium); Pfizer (speakers bureau). Dr. Goode reports relevant financial relationships [vaccines] with Merck, Pfizer, Sanofi, Valneva (honorarium).
The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.
TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter or Prescriber’s Letter account and look for the title of this podcast in the list of available CE courses.
Claim Credit
The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter and Prescriber’s Letter:
- Chart: Flu Vaccines for 2023-2024
If you’re not yet a Pharmacist’s Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com.
Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.
You can also reach out to provide feedback or make suggestions by emailing us at [email protected].
Meds for Obesity and Weight Loss
Medication Talk
03/01/24 • 33 min
Special guest Jennifer N. Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM, Clinical Professor and Director of Pharmacy Education from the University of South Carolina College of Pharmacy joins us to talk about meds for obesity and weight loss.
Listen in as they discuss management of overweight and obesity, including the role of newer injectable medications, oral options, and lifestyle changes.
You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:
- Stephen Carek, MD, CAQSM, DipABLM, Clinical Assistant Professor of Family Medicine, Prisma Health/USC-SOMG Family Medicine Residency Program at the USC School of Medicine Greenville
- Andrea Darby Stewart, MD, Associate Director, Honor Health Family Medicine Residency Program and Clinical Professor of Family, Community & Occupational Medicine at the University of Arizona College of Medicine - Phoenix
- Craig D. Williams, PharmD, FNLA, BCPS, Clinical Professor of Pharmacy Practice at the Oregon Health and Science University
For the purposes of disclosure, Dr. Clements reports relevant financial relationships [GLP-1 agonists] with Eli Lilly, Novo Nordisk (speakers bureau).
TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.
Claim Credit
The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter and Prescriber Insights:
If you’re not yet a Pharmacist’s Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com.
Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.
You can also reach out to provide feedback or make suggestions by emailing us at [email protected].
Pharmacotherapy for Anxiety and Depression
Medication Talk
07/01/24 • 31 min
Special guest Marshall E. Cates, PharmD, BCPP, FASHP, FCCP, FALSHP, Professor of Pharmacy Practice from the McWhorter School of Pharmacy at Samford University joins us to talk about pharmacotherapy for anxiety and depression.
Listen in as we discuss pharmacotherapy for managing generalized anxiety disorder and major depression, with a focus on tailoring first- or second-line options to individual patient needs.
You’ll also hear practical advice from Craig D. Williams, PharmD, FNLA, BCPS, a member of TRC’s Editorial Advisory Board and Clinical Professor of Pharmacy Practice at the Oregon Health and Science University.
For the purposes of disclosure, Dr. Cates reports relevant financial relationships [psychiatry] with Biogen, Sage Therapeutics (honorarium); Otsuka (speakers bureau).
The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.
TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.
Claim Credit
The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter and Prescriber Insights:
- Chart: Pharmacotherapy of Anxiety Disorders in Adults
- Chart: Choosing and Switching Antidepressants
- Chart: Combining and Augmenting Antidepressants
If you’re not yet a Pharmacist’s Letter or Prescriber Insights subscriber, find out more about our product offerings at trchealthcare.com.
Follow or subscribe, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.
You can also reach out to provide feedback or make suggestions by emailing us at [email protected].
Show more best episodes
Show more best episodes
FAQ
How many episodes does Medication Talk have?
Medication Talk currently has 33 episodes available.
What topics does Medication Talk cover?
The podcast is about Health & Fitness, Pharmacy, Cme, Medical, Drug, Medicine, Courses, Podcasts, Education, Pharmaceutical and Healthcare.
What is the most popular episode on Medication Talk?
The episode title 'Flu Vaccine Updates' is the most popular.
What is the average episode length on Medication Talk?
The average episode length on Medication Talk is 30 minutes.
How often are episodes of Medication Talk released?
Episodes of Medication Talk are typically released every 30 days, 1 hour.
When was the first episode of Medication Talk?
The first episode of Medication Talk was released on Apr 22, 2022.
Show more FAQ
Show more FAQ